Early cannabis use, polygenic risk score for schizophrenia, and brain maturation in adolescence

JAMA Psychiatry

Volumn 72, Issue 10, 2015, Pages 1002-1011

  French, Leon ^a   Gray, Courtney ^a   Leonard, Gabriel ^b   Perron, Michel ^c,d   Pike, G Bruce ^e   Richer, Louis ^d   Séguin, Jean R ^f   Veillette, Suzanne ^c,d   Evans, C John ^g   Artiges, Eric ^h,i,j   Banaschewski, Tobias ^k   Bokde, Arun W L ^l   Bromberg, Uli ^m   Bruehl, Ruediger ⁿ   Buchel, Christian ^m   Cattrell, Anna ^o,p   Conrod, Patricia J ^f,o   Flor, Herta ^k   Frouin, Vincent ^q   Gallinat, Jurgen ^m   Garavan, Hugh ^r,s   Gowland, Penny ^t   Heinz, Andreas ^u   Lemaitre, Herve ^h,i,j   Martinot, Jean Luc ^h,i,j   Nees, Frauke ^k   Orfanos, Dimitri Papadopoulos ^q   Pangelinan, Melissa Marie ^a   Poustka, Luise ^k   Rietschel, Marcella ^k   Smolka, Michael N ^v   Walter, Henrik ^u   Whelan, Robert ^w   Timpson, Nic J ^x   Schumann, Gunter ^o,p   Smith, George Davey ^x   Pausova, Zdenka ^y,z,aa   Paus, Tomáš ^a,aa,ab   more..

^a ROTMAN RESEARCH INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Cégep de Jonquiere   (Canada)

^d UNIVERSITÉ DU QUÉBEC À CHICOUTIMI   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^g CARDIFF UNIVERSITY   (United Kingdom)

^h DIF   (France)

ⁱ INSERM   (France)

^j ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^k UNIVERSITY OF HEIDELBERG   (Germany)

^l TRINITY COLLEGE DUBLIN   (Ireland)

^m UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁿ PHYSIKALISCH TECHNISCHE BUNDESANSTALT   (Germany)

^o KING'S COLLEGE LONDON   (United Kingdom)

^p KING'S COLLEGE LONDON   (United Kingdom)

^q CEA SACLAY   (France)

^r UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^s UNIVERSITY OF VERMONT   (United States)

^t UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^u CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^v DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^w UNIVERSITY COLLEGE DUBLIN   (Ireland)

^x UNIVERSITY OF BRISTOL   (United Kingdom)

^y HOSPITAL FOR SICK CHILDREN   (Canada)

^z UNIVERSITY OF TORONTO   (Canada)

^aa UNIVERSITY OF TORONTO   (Canada)

^ab CHILD MIND INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABIS;

ADOLESCENCE; ADOLESCENT; ADULT; ANTERIOR CINGULATE; ARTICLE; BRAIN MATURATION; CANNABIS USE; CHILD; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); ENTORHINAL CORTEX; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE LOCUS; GENETIC RISK; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYGENIC RISK SCORE; PROTEIN EXPRESSION; SCHIZOPHRENIA; SCORING SYSTEM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VULNERABLE POPULATION; ADOLESCENT DEVELOPMENT; BRAIN; BRAIN CORTEX; CANNABIS SMOKING; COHORT ANALYSIS; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; GROWTH, DEVELOPMENT AND AGING; LONGITUDINAL STUDY; ONSET AGE; PROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADOLESCENT DEVELOPMENT; AGE OF ONSET; BRAIN; CEREBRAL CORTEX; CHILD; COHORT STUDIES; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA SMOKING; PROSPECTIVE STUDIES; RISK ASSESSMENT; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84943531741     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.1131     Document Type: Article

References (61)

1. United Nations Office on Drugs and Crime.World Drug Report 2014. New York, NY: United Nations; June 2014.
2. Degenhardt L, Ferrari AJ, Calabria B, et al. The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study. PLoS One. 2013;8(10):e76635. doi:10.1371/journal.pone .0076635.
3. Hibell BGU, Ahlstrom S, Balakireva O, Bjarnason T, Kokkevi A, Kraus L. The 2011 ESPAD Report: Substance Use Among Students in 36 European Countries. Stockholm, Sweden: European School Survey Project on Alcohol and Other Drugs; May 2012.
4. Johnston LD, O'Malley PM, Miech RA, Bachman JG, Schulenberg JE. Monitoring the Future: National Results on Drug Use: 1975-2013: Overview, Key Findings on Adolescent Drug Use. Ann Arbor: Institute for Social Research, The University of Michigan; 2014.
5. Sisk CL, Foster DL. The neural basis of puberty and adolescence. Nat Neurosci. 2004;7(10):1040-1047.
6. Blakemore SJ, Mills KL. Is adolescence a sensitive period for sociocultural processing? Annu Rev Psychol. 2014;65:187-207.
7. Paus T. Mapping brain maturation and cognitive development during adolescence. Trends Cogn Sci. 2005;9(2):60-68.
8. Paus T. Growth of white matter in the adolescent brain:myelin or axon? Brain Cogn. 2010;72(1):26-35.
9. Paus T. How environment and genes shape the adolescent brain. Horm Behav. 2013;64(2):195-202.
10. Casey BJ, Getz S, Galvan A. The adolescent brain. Dev Rev. 2008;28(1):62-77.
11. Lenroot RK, Giedd JN. Sex differences in the adolescent brain. Brain Cogn. 2010;72(1):46-55.
12. Luna B, Padmanabhan A, O'Hearn K. What has fMRI told us about the development of cognitive control through adolescence? Brain Cogn. 2010;72 (1):101-113.
13. Paus T, Nawaz-Khan I, Leonard G, et al. Sexual dimorphism in the adolescent brain: role of testosterone and androgen receptor in global and local volumes of grey and white matter. Horm Behav. 2010;57(1):63-75.
14. Lenroot RK, Gogtay N, Greenstein DK, et al. Sexual dimorphism of brain developmental trajectories during childhood and adolescence. Neuroimage. 2007;36(4):1065-1073.
15. Häfner H, an der Heiden W, Behrens S, et al. Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophr Bull. 1998;24(1):99-113.
16. Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Andreasson S, Allebeck P. Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort. Psychol Med. 2012;42(6): 1321-1328.
17. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421-427.
18. Pausova Z, Paus T, Abrahamowicz M, et al. Genes, maternal smoking, and the offspring brain and body during adolescence: design of the Saguenay Youth Study. Hum Brain Mapp. 2007;28 (6):502-518.
19. De Braekeleer M. Hereditary disorders in Saguenay-Lac-St-Jean (Quebec, Canada). Hum Hered. 1991;41(3):141-146.
20. Boyd A, Golding J, Macleod J, et al. Cohort profile: the "children of the 90s" - the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol. 2013;42(1):111-127.
21. Schumann G, Loth E, Banaschewski T, et al; IMAGEN Consortium. The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry. 2010;15(12):1128-1139.
22. Cheetham A, Allen NB, Whittle S, Simmons JG, Yücel M, Lubman DI. Orbitofrontal volumes in early adolescence predict initiation of cannabis use: a 4-year longitudinal and prospective study. Biol Psychiatry. 2012;71(8):684-692.
23. Batalla A, Soriano-Mas C, López-SolàM, et al. Modulation of brain structure by catechol-Omethyltransferase Val(158) Met polymorphism in chronic cannabis users. Addict Biol. 2014;19(4):722-732.
24. Zalesky A, Solowij N, Yücel M, et al. Effect of long-term cannabis use on axonal fibre connectivity. Brain. 2012;135(pt 7):2245-2255.
25. Sirevaag AM, Greenough WT. A multivariate statistical summary of synaptic plasticity measures in rats exposed to complex, social and individual environments. Brain Res. 1988;441(1-2):386-392.
26. Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature. 2012;489 (7416):391-399.
27. R Core Team. A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2014.
28. Desikan RS, Ségonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31(3): 968-980.
29. Ebrahim S, Davey Smith G. Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum Genet. 2008;123(1):15-33.
30. Keshavan M, Giedd J, Lau JYF, Lewis DA, Paus T. Changes in the adolescent brain and the pathophysiology of psychotic disorders. Lancet Psychiatry. 2014;1(7):549-558.
31. Rapoport JL, Giedd JN, Blumenthal J, et al. Progressive cortical change during adolescence in childhood-onset schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 1999;56(7):649-654.
32. Thompson PM, Vidal C, Giedd JN, et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci U S A. 2001;98(20):11650-11655.
33. Mattai AA, Weisinger B, Greenstein D, et al. Normalization of cortical gray matter deficits in nonpsychotic siblings of patients with childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry. 2011;50(7):697-704.
34. Ahn K, An SS, Shugart YY, Rapoport JL. Common polygenic variation and risk for childhood-onset schizophrenia [published online December 16, 2014]. Mol Psychiatry. doi:10.1038 /mp.2014.158.
35. Pope HG Jr, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend. 2003;69(3): 303-310.
36. Fontes MA, Bolla KI, Cunha PJ, et al. Cannabis use before age 15 and subsequent executive functioning. Br J Psychiatry. 2011;198(6):442-447.
37. Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry. 2005;57 (10):1117-1127.
38. Wilson W, Mathew R, Turkington T, Hawk T, Coleman RE, Provenzale J. Brain morphological changes and early marijuana use: amagnetic resonance and positron emission tomography study. J Addict Dis. 2000;19(1):1-22.
39. Draganski B, Gaser C, Busch V, Schuierer G, Bogdahn U, May A. Neuroplasticity: changes in grey matter induced by training. Nature. 2004;427 (6972):311-312.
40. Draganski B, May A. Training-induced structural changes in the adult human brain. Behav Brain Res. 2008;192(1):137-142.
41. Navakkode S, Korte M. Pharmacological activation of CB1 receptor modulates long term potentiation by interfering with protein synthesis. Neuropharmacology. 2014;79:525-533.
42. Collins DR, Pertwee RG, Davies SN. Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice. Br J Pharmacol. 1995;115(6):869-870.
43. Davies SN, Pertwee RG, Riedel G. Functions of cannabinoid receptors in the hippocampus. Neuropharmacology. 2002;42(8):993-1007.
44. Galve-Roperh I, Chiurchiù V, Díaz-Alonso J, Bari M, Guzmán M, Maccarrone M. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation. Prog Lipid Res. 2013;52(4):633-650.
45. D'Souza DC, Pittman B, Perry E, Simen A. Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans. Psychopharmacology (Berl). 2009;202(4): 569-578.
46. Angelucci F, Ricci V, Spalletta G, et al. Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers. Eur Neuropsychopharmacol. 2008;18(12):882-887.
47. Verweij KJ, Huizink AC, Agrawal A, Martin NG, Lynskey MT. Is the relationship between early-onset cannabis use and educational attainment causal or due to common liability? Drug Alcohol Depend. 2013;133(2):580-586.
48. Leach LS, Butterworth P. The effect of early onset common mental disorders on educational attainment in Australia. Psychiatry Res. 2012;199(1): 51-57.
49. Horwood LJ, Fergusson DM, Hayatbakhsh MR, et al. Cannabis use and educational achievement: findings from three Australasian cohort studies. Drug Alcohol Depend. 2010;110(3):247-253.
50. Henchoz Y, Dupuis M, Deline S, et al. Associations of physical activity and sport and exercise with at-risk substance use in young men: a longitudinal study. Prev Med. 2014;64:27-31.
51. Koolschijn PC, Peper JS, Crone EA. The influence of sex steroids on structural brain maturation in adolescence. PLoS One. 2014;9(1): e83929. doi:10.1371/journal.pone.0083929.
52. Nguyen TV, Mc Cracken J, Ducharme S, et al; Brain Development Cooperative Group. Testosterone-related cortical maturation across childhood and adolescence. Cereb Cortex. 2013;23 (6):1424-1432.
53. Leranth C, Petnehazy O, Mac Lusky NJ. Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J Neurosci. 2003;23(5):1588-1592.
54. Paus T, Pesaresi M, French L. White matter as a transport system. Neuroscience. 2014;276:117-125.
55. Pesaresi M, Soon-Shiong R, French L, Miller FD, Paus T; D R Kaplan.Axon diameter and axonal transport: In vivo and in vitro effects of androgens. Neuroimage. 2015;115:191-201.25956809
56. Tarter RE, Kirisci L, Gavaler JS, et al. Prospective study of the association between abandoned dwellings and testosterone level on the development of behaviors leading to cannabis use disorder in boys. Biol Psychiatry. 2009;65(2):116-121.
57. Borgquist A, Meza C, Wagner EJ. The role of AMP-activated protein kinase (AMPK) in the androgenic potentiation of cannabinoid-induced changes in energy homeostasis. Am J Physiol Endocrinol Metab. 2015;308(6):E482-E495. doi:10 .1152/ajpendo.00421.2014.
58. Lee KS, Asgar J, Zhang Y, Chung MK, Ro JY. The role of androgen receptor in transcriptional modulation of cannabinoid receptor type 1 gene in rat trigeminal ganglia. Neuroscience. 2013;254:395-403.
59. Busch L, Sterin-Borda L, Borda E. Effects of castration on cannabinoid CB receptor expression and on the biological actions of cannabinoid in the parotid gland. Clin Exp Pharmacol Physiol. 2006;33 (3):258-263.
60. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013; 381(9875):1371-1379.
61. Maynard TM, Sikich L, Lieberman JA, LaMantia AS. Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia. Schizophr Bull. 2001;27(3):457-476.